These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22723550)

  • 1. Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway.
    Tey SK; Khanna R
    Blood; 2012 Aug; 120(5):994-1004. PubMed ID: 22723550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immune system strikes back: autophagy-mediated antigen presentation bypasses viral blockade of the classic MHC class I processing pathway.
    Tey SK; Khanna R
    Autophagy; 2012 Dec; 8(12):1839-41. PubMed ID: 22932396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of autophagy in MHC class I antigen presentation.
    Øynebråten I
    Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells.
    Dasari V; Rehan S; Tey SK; Smyth MJ; Smith C; Khanna R
    Immunol Cell Biol; 2016 Nov; 94(10):964-974. PubMed ID: 27297581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
    Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
    J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
    Lautscham G; Rickinson A; Blake N
    Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
    Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM
    J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.
    Dörfel D; Appel S; Grünebach F; Weck MM; Müller MR; Heine A; Brossart P
    Blood; 2005 Apr; 105(8):3199-205. PubMed ID: 15618468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
    Yang B; Hahn YS; Hahn CS; Braciale TJ
    J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation.
    Bomberger JM; Ely KH; Bangia N; Ye S; Green KA; Green WR; Enelow RI; Stanton BA
    J Biol Chem; 2014 Jan; 289(1):152-62. PubMed ID: 24247241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
    Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
    J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.